Sign in →

Test Code GTT Glucose Tolerance Test

Additional Codes

GL50

GT2

GTT3

GT4

GT5

GTT6

Clinical Significance

Glucose measurements are used in the diagnosis and treatment of carbohydrate metabolism disorders including diabetes mellitus, neonatal hypoglycemia, idiopathic hypoglycemia, and pancreatic islet cell carcinoma. Oral glucose tolerance tests are performed to establish a diagnosis:

  • In patients with transient or sustained glucosuria who have no clinical symptoms of diabetes (polyuria) and with normal fasting and postprandial blood glucose levels.
  • In patients with symptoms of diabetes but with no glucosuria and normal fasting levels.
  • In persons with a strong family history of diabetes, but with no overt symptoms.
  • In patients whose glucosuria is associated with pregnancy, thyrotoxicosis, liver disease, and/or infections.
  • In women who have characteristically large (>4000 gm) babies.
  • In patients with neuropathies and retinopathies of undetermined origin.

Patients with mild or diet-controlled diabetes may have fasting blood glucose levels within the normal range, but be unable to produce sufficient insulin for prompt metabolism of ingested carbohydrate. As a result, blood glucose rises to abnormally high levels and the return to normal is delayed. In other words, the patient has a decreased tolerance for glucose. Therefore, glucose tolerance tests are most helpful in establishing a diagnosis of a mild case of diabetes.

 

When a standard dose of 100 grams of glucose is given orally, absorption occurs rapidly and the blood glucose concentration increases. In a normal patient, this stimulates the pancreas to produce more insulin with the result that after 30 to 60 minutes the blood level of glucose begins to decrease. Since there now exists more insulin than necessary, the blood glucose tends to drop below the fasting level after 1.5 to 2 hours, and then returns to normal levels around 3 hours. Response to glucose in various conditions is shown with a glucose tolerance curve.

 

In a normal response the fasting level of serum glucose is within normal limits, the peak concentration is reached 30 to 60 minutes and does not exceed 170 mg/dL. If the values in the first hour show a rapid fall to normal values or a flat curve with no appreciable rise usually reflect primary alterations in intestinal absorptive states. A very flat rise in blood glucose followed by a prolonged and pronounced hypoglycemic phase may be observed in primary and secondary hyperinsulinism.

Methodology

Oxygen rate method (Beckman Coulter UniCel DxC 660i)

Special Instructions

GL50 - Patient does not have to be fasting, 50g glucose dose is given and sample is drawn at 1 hour.

GT2 - Patient must be fasting 12 hours, a fasting sample is collected, and the patient is given a 75g glucose dose and drawn 2 hours later.

GTT3 - Patient must be fasting 12 hours, a fasting sample is collected, and the patient is given a 100g glucose dose and drawn at 30 minutes, 1, 2, and 3 hours.

GT4 - Patient must be fasting 12 hours, a fasting sample is collected, and the patient is given a 100g glucose dose and drawn at 30 minutes, 1, 2, 3, and 4 hours.

GTT6 - Patient must be fasting 12 hours, a fasting sample is collected, and the patient is given a 100g glucose dose and drawn at 30 minutes, 1, 2, 3, 4, 5 and 6 hours.

 

Note: For children it is 1.75g per kg of body weight. Remove excess drink to equal correct concentration.

Sample Type

Preferred Sample Type
Light green top - Plasma

 

Acceptable Sample Type(s)
Yellow top - Serum

Centrifuge: Yes

Specimen Minimum Volume

0.5 mL

Specimen Stability

Temperature Time
Ambient (18-25°C) 8 hours
Refrigerated (2-8°C) (store) 48 hours
Frozen (-15 to -20°C) 1 month

Separate plasma or serum from cells within 2 hours.

Reference Ranges

Normal Ranges
Sample Interval Age Units (mg/dL)
Fasting <1 month 40 - 90
>1 month 60 - 100
Test Sample Interval Units (mg/dL)
GL50* 1 hour <140
GT2 2 hours <155
GT3 30 minutes 110 - 170
1 hour <180
2 hours <155
3 hours <140
GT4 30 minutes 110 - 170
1 hour <180
2 hours <155
3 hours <140
4 hours Not established
GTT6 30 minutes 110 - 170
1 hour <180
2 hours <155
3 hours <140
4 hours Not established
5 hours Not established
6 hours Not established

*Patient does not need to be fasting. Baseline sample not collected.

 

Critical Values
Sample Interval Age Units (mg/dL)
Fasting** <1 month <30 or >299
>1 month <51 or >499

 **If the fasting glucose is above 200 mg/dL, the ordering physician should be notified immediately. If testing is to proceed a pathologist should be consulted for approval.

 

Technical Range
10 - 2,000 mg/dL

Rejection Criteria

Hemolysis N/A
Icterus N/A
Lipemia 3+ or greater, ultracentrifuge

 

Availability

Performed STAT
24/7 No

 

Performing Laboratory

MulltiCare Yakima Memorial Hospital Laboratory

Lab Department

Chemistry

CPT Code

GL50     82947

GT2       82947 (x2)

GT3       82951 + 82952 (x2)

GT4       82951 + 82952 (x3)

GTT6     82951 + 82952 (x5)
 

LOINC

1547-9     Glucose baseline [Mass/Vol]

1558-6     Glucose post fast [Mass/Vol]

20439-6   Glucose 30 Min post dose glucose [Mass/Vol]

20438-8   Glucose 1 Hr post dose glucose [Mass/Vol]

20436-2   Glucose 2 Hr post dose glucose [Mass/Vol]

20437-0   Glucose 3 Hr post dose glucose [Mass/Vol]

26541-3   Glucose 4 Hr post dose glucose [Mass/Vol]

26543-9   Glucose 5 Hr post dose glucose [Mass/Vol]

26544-7   Glucose 6 Hr post dose glucose [Mass/Vol]